"checkpoint inhibitor associated pneumonia" trang 6 - tải miễn phí từ tailieuXANH
Systematic profiling of diagnostic and prognostic value of autophagy-related genes for sarcoma patients

Systematic profiling of diagnostic and prognostic value of autophagy-related genes for sarcoma patients
10    56    1
Clinical factors associated with shorter durable response, and patterns of acquired resistance to first-line pembrolizumab monotherapy in PD-L1-positive non-smallcell lung cancer patients: A retrospective multicenter study

Clinical factors associated with shorter durable response, and patterns of acquired resistance to first-line pembrolizumab monotherapy in PD-L1-positive non-smallcell lung cancer patients: A retrospective multicenter study
11    37    1
A composite biomarker of neutrophillymphocyte ratio and hemoglobin level correlates with clinical response to PD-1 and PD-L1 inhibitors in advanced non-small cell lung cancers

A composite biomarker of neutrophillymphocyte ratio and hemoglobin level correlates with clinical response to PD-1 and PD-L1 inhibitors in advanced non-small cell lung cancers
11    50    1
IgG4-related pleural disease in a patient with pulmonary adenocarcinoma under durvalumab treatment: A case report

IgG4-related pleural disease in a patient with pulmonary adenocarcinoma under durvalumab treatment: A case report
5    53    1
Nintedanib allows retreatment with atezolizumab of combined non-small cell lung cancer/idiopathic pulmonary fibrosis after atezolizumab-induced pneumonitis: A case report

Nintedanib allows retreatment with atezolizumab of combined non-small cell lung cancer/idiopathic pulmonary fibrosis after atezolizumab-induced pneumonitis: A case report
5    50    1
High incidence and early onset of nivolumab-induced pneumonitis: Four case reports and literature review

High incidence and early onset of nivolumab-induced pneumonitis: Four case reports and literature review
7    45    1
Emerging avenues in immunotherapy for the management of malignant pleural mesothelioma

Emerging avenues in immunotherapy for the management of malignant pleural mesothelioma
24    40    1
Dlx5 and Dlx6 can antagonize cell division at the G1/S checkpoint

Dlx5 and Dlx6 can antagonize cell division at the G1/S checkpoint
12    208    1
MHC class II restricted neoantigen peptides predicted by clonal mutation analysis in lung adenocarcinoma patients: Implications on prognostic immunological biomarker and vaccine design

MHC class II restricted neoantigen peptides predicted by clonal mutation analysis in lung adenocarcinoma patients: Implications on prognostic immunological biomarker and vaccine design
9    52    1
Identification of prognostic markers for hepatocellular carcinoma based on the epithelial-mesenchymal transition-related gene BIRC5

Identification of prognostic markers for hepatocellular carcinoma based on the epithelial-mesenchymal transition-related gene BIRC5
13    141    1
The DANTE trial protocol: A randomised phase III trial to evaluate the Duration of ANti-PD-1 monoclonal antibody Treatment in patients with metastatic mElanoma

The DANTE trial protocol: A randomised phase III trial to evaluate the Duration of ANti-PD-1 monoclonal antibody Treatment in patients with metastatic mElanoma
10    224    1
Prospective correlation between the patient microbiome with response to and development of immune-mediated adverse effects to immunotherapy in lung cancer

Prospective correlation between the patient microbiome with response to and development of immune-mediated adverse effects to immunotherapy in lung cancer
14    169    1
Correlation between immune-related adverse events and therapeutic efects of nivolumab in patients with malignant pleural mesothelioma

Correlation between immune-related adverse events and therapeutic efects of nivolumab in patients with malignant pleural mesothelioma
6    82    1
Ferroptosis regulators, especially SQLE, play an important role in prognosis, progression and immune environment of breast cancer

Ferroptosis regulators, especially SQLE, play an important role in prognosis, progression and immune environment of breast cancer
19    110    1
Tumor-immune profiling of CT-26 and Colon 26 syngeneic mouse models reveals mechanism of anti-PD-1 response

Tumor-immune profiling of CT-26 and Colon 26 syngeneic mouse models reveals mechanism of anti-PD-1 response
12    38    1
Comparison of tumor mutation burden of 300 various non-Hodgkin lymphomas using panel based massively parallel sequencing

Comparison of tumor mutation burden of 300 various non-Hodgkin lymphomas using panel based massively parallel sequencing
11    262    1
HPV-specific risk assessment of cervical cytological abnormalities

HPV-specific risk assessment of cervical cytological abnormalities
6    33    1
Effcacy of immune checkpoint inhibitors in non-small cell lung cancer with uncommon histology: A propensity-score-matched analysis

Effcacy of immune checkpoint inhibitors in non-small cell lung cancer with uncommon histology: A propensity-score-matched analysis
9    195    1
Current state of knowledge on immunotherapy in ECOG PS 2 patients. A systematic review

Current state of knowledge on immunotherapy in ECOG PS 2 patients. A systematic review
7    258    1
Association of advanced age and cancer history with autoimmune disease in melanoma patients: A cross-sectional study

Association of advanced age and cancer history with autoimmune disease in melanoma patients: A cross-sectional study
8    178    2
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.